Organism: Homo sapiens
Gene: 38519_at
Selected probe(set): 206340_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38519_at (206340_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-5.0305834
Number of Samples:24 / 3

Experimental	colorectal cancer study 4 (recurring)
	LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer. Patients developed metastatic recurrence during follow-up after surgery.
Control	adjacent colon tissue (recurring)
	Histologically normal colon tissue samples from patients with primary colorectal cancer collected after resection. Tissue was further extracted using laser-capture microdissection (LCM). With metastatic recurrence after resection during follow-up.

Relative Expression (log2-ratio):-3.997013
Number of Samples:2 / 18

Experimental	renal cell carcinoma study 10 (PDX; clear cell adenocarcinoma, NOS; metastatic)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from a metastasis of patients with primary clear cell adenocarcinoma, NOS of the kidney (subcutaneously implanted). Metastatic site of patient tumor sample is not reported.
Control	renal cell carcinoma study 10 (PDX; clear cell adenocarcinoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary clear cell adenocarcinoma, NOS of the kidney (subcutaneously implanted).

Relative Expression (log2-ratio):-3.4661036
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	normal colon mucosa sample
	Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):3.3925695
Number of Samples:22 / 4

Experimental	expO kidney cancer study 1 (papillary adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with papillary adenocarcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-3.3614302
Number of Samples:4 / 4

Experimental	ovarian tumor study 14
	Human pooled cancer samples from the ovary of patients with moderate and poorly differentiated serous carcinoma of the ovary.
Control	normal ovarian surface epithelial cell sample
	Human epithelial cell samples from histopathological normal and non-cancerous ovary tissue from donors with non-cancerous, benign gynecological diseases.

Relative Expression (log2-ratio):-3.3379793
Number of Samples:8 / 12

Experimental	hepatocyte (ESC)
	Hepatocyte-like cells differentiated from embryonic stem cells (ESC)
Control	HepaRG
	Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code:

Relative Expression (log2-ratio):-3.3166075
Number of Samples:3 / 9

Experimental	PMA study 8 (0.0001 uM; Hep-G2)
	Hep-G2 cells exposed to 0.0001 uM PMA (dissolved in 0.5% v/v DMSO) for 72 hours. Synonyms: phorbol-12-myristat-13-acetate (PMA), tetradecanoylphorbol-acetate (TPA), tetradecanoyl phorbol acetate, 12-O-tetradecanoylphorbol-13-acetate. Cells were exposed to the chemical when 80% confluence was reached. Cells were treated with the IC10 determined by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test (number of replicates, n = 3). ATC code:---
Control	vehicle (DMSO) treated Hep-G2 cell sample
	Hep-G2 cells treated with vehicle (DMSO 0.5% v/v) for 72 hours. Cells were exposed to the vehicle when 80% confluence was reached.

Relative Expression (log2-ratio):-3.2774038
Number of Samples:5 / 5

Experimental	colorectal adenoma study 7 (colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control	normal colon mucosa sample
	Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):3.1949263
Number of Samples:5 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):3.0395994
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, sarcomatoid; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma, sarcomatoid.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.